Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | > | 50000 | nM | 21513293 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | > | 25000 | nM | 21513293 |
NPT395 | Cell Line | SF-268 | Homo sapiens | IC50 | > | 50000 | nM | 21513293 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | > | 50000 | nM | 21513293 |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | IC50 | > | 50000 | nM | 21513293 |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | IC50 | > | 50000 | nM | 21513293 |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 500 | ug/ml | 21513293 |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 500 | ug/ml | 21513293 |
NPT602 | Organism | Mycobacterium smegmatis | Mycobacterium smegmatis | MIC | > | 500 | ug/ml | 21513293 |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | > | 500 | ug/ml | 21513293 |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 1995.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 7307.8 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 8199.5 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 14581 | nM | PubChem BioAssay data set | |
NPT3442 | Individual Protein | Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens | IC50 | = | 2600 | nM | 26481152 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC210320 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9929 | High Similarity | NPC215711 |
0.9929 | High Similarity | NPC73411 |
0.9786 | High Similarity | NPC280404 |
0.9786 | High Similarity | NPC277426 |
0.9786 | High Similarity | NPC86373 |
0.9786 | High Similarity | NPC210425 |
0.9643 | High Similarity | NPC474385 |
0.9524 | High Similarity | NPC99381 |
0.95 | High Similarity | NPC158472 |
0.9444 | High Similarity | NPC472036 |
0.9441 | High Similarity | NPC472034 |
0.9437 | High Similarity | NPC51106 |
0.9437 | High Similarity | NPC472006 |
0.9433 | High Similarity | NPC475730 |
0.9433 | High Similarity | NPC1704 |
0.9433 | High Similarity | NPC67650 |
0.9384 | High Similarity | NPC469619 |
0.9384 | High Similarity | NPC469670 |
0.9375 | High Similarity | NPC472033 |
0.9357 | High Similarity | NPC478200 |
0.9357 | High Similarity | NPC33144 |
0.932 | High Similarity | NPC200773 |
0.932 | High Similarity | NPC70016 |
0.932 | High Similarity | NPC240768 |
0.932 | High Similarity | NPC215921 |
0.9301 | High Similarity | NPC469542 |
0.9296 | High Similarity | NPC244923 |
0.9296 | High Similarity | NPC158634 |
0.9286 | High Similarity | NPC135837 |
0.9267 | High Similarity | NPC246466 |
0.9257 | High Similarity | NPC478224 |
0.9252 | High Similarity | NPC56204 |
0.9252 | High Similarity | NPC472891 |
0.9247 | High Similarity | NPC471641 |
0.9247 | High Similarity | NPC240253 |
0.9247 | High Similarity | NPC471642 |
0.9247 | High Similarity | NPC240622 |
0.9241 | High Similarity | NPC107625 |
0.9231 | High Similarity | NPC469579 |
0.922 | High Similarity | NPC191835 |
0.922 | High Similarity | NPC212693 |
0.922 | High Similarity | NPC94248 |
0.9184 | High Similarity | NPC4423 |
0.9184 | High Similarity | NPC77325 |
0.9184 | High Similarity | NPC270160 |
0.9184 | High Similarity | NPC237440 |
0.9184 | High Similarity | NPC476684 |
0.9178 | High Similarity | NPC14098 |
0.9172 | High Similarity | NPC83272 |
0.9161 | High Similarity | NPC478217 |
0.9161 | High Similarity | NPC313123 |
0.9161 | High Similarity | NPC472035 |
0.9161 | High Similarity | NPC478201 |
0.9155 | High Similarity | NPC268052 |
0.9155 | High Similarity | NPC32360 |
0.9155 | High Similarity | NPC52358 |
0.9149 | High Similarity | NPC70380 |
0.9143 | High Similarity | NPC182496 |
0.9143 | High Similarity | NPC180905 |
0.9133 | High Similarity | NPC170189 |
0.9133 | High Similarity | NPC478230 |
0.9133 | High Similarity | NPC69043 |
0.9133 | High Similarity | NPC208173 |
0.9128 | High Similarity | NPC184284 |
0.9128 | High Similarity | NPC76041 |
0.9128 | High Similarity | NPC115249 |
0.9097 | High Similarity | NPC250755 |
0.9067 | High Similarity | NPC137301 |
0.9041 | High Similarity | NPC257558 |
0.9041 | High Similarity | NPC312789 |
0.9034 | High Similarity | NPC478202 |
0.9028 | High Similarity | NPC90411 |
0.9021 | High Similarity | NPC139634 |
0.9021 | High Similarity | NPC105456 |
0.9021 | High Similarity | NPC247409 |
0.9014 | High Similarity | NPC71256 |
0.9013 | High Similarity | NPC472889 |
0.9013 | High Similarity | NPC473395 |
0.9007 | High Similarity | NPC79998 |
0.9007 | High Similarity | NPC16082 |
0.9007 | High Similarity | NPC82592 |
0.9007 | High Similarity | NPC472890 |
0.9 | High Similarity | NPC167903 |
0.9 | High Similarity | NPC153783 |
0.8993 | High Similarity | NPC179178 |
0.898 | High Similarity | NPC473023 |
0.8973 | High Similarity | NPC210966 |
0.8973 | High Similarity | NPC95123 |
0.8973 | High Similarity | NPC126882 |
0.8973 | High Similarity | NPC478203 |
0.8973 | High Similarity | NPC66404 |
0.8966 | High Similarity | NPC96692 |
0.8961 | High Similarity | NPC117985 |
0.8954 | High Similarity | NPC470339 |
0.8951 | High Similarity | NPC472602 |
0.8951 | High Similarity | NPC177307 |
0.8951 | High Similarity | NPC9121 |
0.8951 | High Similarity | NPC475974 |
0.8947 | High Similarity | NPC472050 |
0.8944 | High Similarity | NPC235115 |
0.894 | High Similarity | NPC478231 |
0.894 | High Similarity | NPC281477 |
0.8933 | High Similarity | NPC91809 |
0.8926 | High Similarity | NPC84142 |
0.8917 | High Similarity | NPC283041 |
0.8912 | High Similarity | NPC134621 |
0.891 | High Similarity | NPC191930 |
0.8897 | High Similarity | NPC472603 |
0.8897 | High Similarity | NPC472604 |
0.8897 | High Similarity | NPC472605 |
0.8897 | High Similarity | NPC53649 |
0.8896 | High Similarity | NPC472055 |
0.8889 | High Similarity | NPC84935 |
0.8889 | High Similarity | NPC77679 |
0.8889 | High Similarity | NPC478225 |
0.8889 | High Similarity | NPC190020 |
0.8882 | High Similarity | NPC317585 |
0.8882 | High Similarity | NPC478221 |
0.8881 | High Similarity | NPC474849 |
0.8881 | High Similarity | NPC65837 |
0.8881 | High Similarity | NPC474771 |
0.8881 | High Similarity | NPC240147 |
0.8881 | High Similarity | NPC178467 |
0.8881 | High Similarity | NPC149372 |
0.8881 | High Similarity | NPC121243 |
0.8867 | High Similarity | NPC164762 |
0.8867 | High Similarity | NPC96501 |
0.8859 | High Similarity | NPC153417 |
0.8857 | High Similarity | NPC219892 |
0.8857 | High Similarity | NPC189823 |
0.8854 | High Similarity | NPC20237 |
0.8851 | High Similarity | NPC163846 |
0.8851 | High Similarity | NPC237208 |
0.8851 | High Similarity | NPC225173 |
0.8846 | High Similarity | NPC249181 |
0.8844 | High Similarity | NPC151607 |
0.8844 | High Similarity | NPC42540 |
0.8836 | High Similarity | NPC471640 |
0.8836 | High Similarity | NPC82913 |
0.8836 | High Similarity | NPC105648 |
0.8836 | High Similarity | NPC49108 |
0.8836 | High Similarity | NPC471644 |
0.8828 | High Similarity | NPC472601 |
0.8828 | High Similarity | NPC472600 |
0.8828 | High Similarity | NPC165172 |
0.8824 | High Similarity | NPC150227 |
0.8824 | High Similarity | NPC227062 |
0.8819 | High Similarity | NPC472403 |
0.8808 | High Similarity | NPC46882 |
0.8808 | High Similarity | NPC132990 |
0.8803 | High Similarity | NPC175943 |
0.8792 | High Similarity | NPC125801 |
0.8792 | High Similarity | NPC8817 |
0.8792 | High Similarity | NPC259632 |
0.8784 | High Similarity | NPC29577 |
0.8784 | High Similarity | NPC473692 |
0.8776 | High Similarity | NPC159721 |
0.8776 | High Similarity | NPC354984 |
0.8776 | High Similarity | NPC471731 |
0.8776 | High Similarity | NPC471643 |
0.8776 | High Similarity | NPC471639 |
0.8767 | High Similarity | NPC220106 |
0.8766 | High Similarity | NPC478226 |
0.8759 | High Similarity | NPC92655 |
0.8759 | High Similarity | NPC474655 |
0.8758 | High Similarity | NPC80534 |
0.8758 | High Similarity | NPC473241 |
0.8758 | High Similarity | NPC56786 |
0.8758 | High Similarity | NPC199926 |
0.8758 | High Similarity | NPC67396 |
0.875 | High Similarity | NPC473391 |
0.875 | High Similarity | NPC470397 |
0.875 | High Similarity | NPC470338 |
0.875 | High Similarity | NPC474843 |
0.875 | High Similarity | NPC470340 |
0.875 | High Similarity | NPC194579 |
0.875 | High Similarity | NPC268992 |
0.875 | High Similarity | NPC113608 |
0.875 | High Similarity | NPC51824 |
0.875 | High Similarity | NPC472367 |
0.875 | High Similarity | NPC273483 |
0.875 | High Similarity | NPC470337 |
0.875 | High Similarity | NPC476333 |
0.875 | High Similarity | NPC472364 |
0.8742 | High Similarity | NPC295036 |
0.8742 | High Similarity | NPC60413 |
0.8742 | High Similarity | NPC158866 |
0.8742 | High Similarity | NPC85131 |
0.8742 | High Similarity | NPC475460 |
0.8741 | High Similarity | NPC27407 |
0.8741 | High Similarity | NPC142027 |
0.8733 | High Similarity | NPC37139 |
0.8733 | High Similarity | NPC172329 |
0.8733 | High Similarity | NPC218569 |
0.8733 | High Similarity | NPC2569 |
0.8732 | High Similarity | NPC203817 |
0.8725 | High Similarity | NPC138978 |
0.8725 | High Similarity | NPC260946 |
0.8725 | High Similarity | NPC470357 |
0.8718 | High Similarity | NPC317544 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC210320 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9021 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.8716 | High Similarity | NPD6799 | Approved |
0.8658 | High Similarity | NPD2532 | Approved |
0.8658 | High Similarity | NPD2533 | Approved |
0.8658 | High Similarity | NPD2534 | Approved |
0.8645 | High Similarity | NPD7075 | Discontinued |
0.8571 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8571 | High Similarity | NPD7819 | Suspended |
0.8516 | High Similarity | NPD3817 | Phase 2 |
0.8506 | High Similarity | NPD6801 | Discontinued |
0.8497 | Intermediate Similarity | NPD6599 | Discontinued |
0.8462 | Intermediate Similarity | NPD3882 | Suspended |
0.8452 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8411 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8387 | Intermediate Similarity | NPD1934 | Approved |
0.8377 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8355 | Intermediate Similarity | NPD1512 | Approved |
0.8323 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8323 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8323 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8311 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8311 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8301 | Intermediate Similarity | NPD5403 | Approved |
0.8299 | Intermediate Similarity | NPD1510 | Phase 2 |
0.828 | Intermediate Similarity | NPD5402 | Approved |
0.8276 | Intermediate Similarity | NPD1240 | Approved |
0.8267 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8255 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8224 | Intermediate Similarity | NPD1511 | Approved |
0.8217 | Intermediate Similarity | NPD2801 | Approved |
0.8199 | Intermediate Similarity | NPD6232 | Discontinued |
0.8193 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8176 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.817 | Intermediate Similarity | NPD5401 | Approved |
0.8163 | Intermediate Similarity | NPD1607 | Approved |
0.816 | Intermediate Similarity | NPD7473 | Discontinued |
0.8146 | Intermediate Similarity | NPD3750 | Approved |
0.8133 | Intermediate Similarity | NPD7251 | Discontinued |
0.8121 | Intermediate Similarity | NPD2796 | Approved |
0.8095 | Intermediate Similarity | NPD230 | Phase 1 |
0.8089 | Intermediate Similarity | NPD7411 | Suspended |
0.8084 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8061 | Intermediate Similarity | NPD7054 | Approved |
0.8061 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8054 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.805 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8026 | Intermediate Similarity | NPD4628 | Phase 3 |
0.8025 | Intermediate Similarity | NPD6959 | Discontinued |
0.8014 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD7472 | Approved |
0.8012 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8 | Intermediate Similarity | NPD2935 | Discontinued |
0.8 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD3818 | Discontinued |
0.8 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7952 | Intermediate Similarity | NPD5844 | Phase 1 |
0.795 | Intermediate Similarity | NPD3749 | Approved |
0.7919 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7888 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7879 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7866 | Intermediate Similarity | NPD5711 | Approved |
0.7866 | Intermediate Similarity | NPD5710 | Approved |
0.7857 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7821 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7815 | Intermediate Similarity | NPD3748 | Approved |
0.7811 | Intermediate Similarity | NPD6559 | Discontinued |
0.7791 | Intermediate Similarity | NPD919 | Approved |
0.773 | Intermediate Similarity | NPD9545 | Approved |
0.7727 | Intermediate Similarity | NPD2800 | Approved |
0.7727 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7708 | Intermediate Similarity | NPD9717 | Approved |
0.7682 | Intermediate Similarity | NPD6651 | Approved |
0.7679 | Intermediate Similarity | NPD3751 | Discontinued |
0.7667 | Intermediate Similarity | NPD943 | Approved |
0.7654 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7651 | Intermediate Similarity | NPD3787 | Discontinued |
0.7636 | Intermediate Similarity | NPD5494 | Approved |
0.7625 | Intermediate Similarity | NPD3226 | Approved |
0.7616 | Intermediate Similarity | NPD447 | Suspended |
0.7613 | Intermediate Similarity | NPD1243 | Approved |
0.761 | Intermediate Similarity | NPD920 | Approved |
0.7605 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.759 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7589 | Intermediate Similarity | NPD9493 | Approved |
0.7582 | Intermediate Similarity | NPD2799 | Discontinued |
0.7582 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.758 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7564 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7551 | Intermediate Similarity | NPD1203 | Approved |
0.755 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7544 | Intermediate Similarity | NPD5953 | Discontinued |
0.7533 | Intermediate Similarity | NPD411 | Approved |
0.7532 | Intermediate Similarity | NPD6100 | Approved |
0.7532 | Intermediate Similarity | NPD6099 | Approved |
0.7517 | Intermediate Similarity | NPD422 | Phase 1 |
0.7517 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7516 | Intermediate Similarity | NPD6190 | Approved |
0.75 | Intermediate Similarity | NPD2654 | Approved |
0.75 | Intermediate Similarity | NPD6355 | Discontinued |
0.75 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7486 | Intermediate Similarity | NPD7435 | Discontinued |
0.7486 | Intermediate Similarity | NPD8150 | Discontinued |
0.7485 | Intermediate Similarity | NPD37 | Approved |
0.7484 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7484 | Intermediate Similarity | NPD2346 | Discontinued |
0.747 | Intermediate Similarity | NPD6234 | Discontinued |
0.7468 | Intermediate Similarity | NPD7033 | Discontinued |
0.7455 | Intermediate Similarity | NPD4965 | Approved |
0.7455 | Intermediate Similarity | NPD4966 | Approved |
0.7455 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7444 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7427 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7421 | Intermediate Similarity | NPD7390 | Discontinued |
0.7418 | Intermediate Similarity | NPD6782 | Approved |
0.7418 | Intermediate Similarity | NPD6778 | Approved |
0.7418 | Intermediate Similarity | NPD6776 | Approved |
0.7418 | Intermediate Similarity | NPD6777 | Approved |
0.7418 | Intermediate Similarity | NPD6780 | Approved |
0.7418 | Intermediate Similarity | NPD6779 | Approved |
0.7418 | Intermediate Similarity | NPD6781 | Approved |
0.7417 | Intermediate Similarity | NPD6798 | Discontinued |
0.7414 | Intermediate Similarity | NPD8313 | Approved |
0.7414 | Intermediate Similarity | NPD8312 | Approved |
0.7407 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7401 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7381 | Intermediate Similarity | NPD1247 | Approved |
0.7379 | Intermediate Similarity | NPD4626 | Approved |
0.7372 | Intermediate Similarity | NPD2344 | Approved |
0.7356 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7347 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7347 | Intermediate Similarity | NPD1608 | Approved |
0.7333 | Intermediate Similarity | NPD9494 | Approved |
0.733 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7312 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD5691 | Approved |
0.7308 | Intermediate Similarity | NPD5405 | Approved |
0.7308 | Intermediate Similarity | NPD5404 | Approved |
0.7308 | Intermediate Similarity | NPD5406 | Approved |
0.7308 | Intermediate Similarity | NPD5408 | Approved |
0.7303 | Intermediate Similarity | NPD3764 | Approved |
0.7303 | Intermediate Similarity | NPD3268 | Approved |
0.7287 | Intermediate Similarity | NPD8151 | Discontinued |
0.7278 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7273 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7273 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD2798 | Approved |
0.7267 | Intermediate Similarity | NPD5647 | Approved |
0.7267 | Intermediate Similarity | NPD7228 | Approved |
0.7267 | Intermediate Similarity | NPD1019 | Discontinued |
0.7261 | Intermediate Similarity | NPD5762 | Approved |
0.7261 | Intermediate Similarity | NPD5763 | Approved |
0.726 | Intermediate Similarity | NPD1778 | Approved |
0.7255 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7249 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7249 | Intermediate Similarity | NPD7874 | Approved |
0.7239 | Intermediate Similarity | NPD1653 | Approved |
0.7235 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7222 | Intermediate Similarity | NPD6273 | Approved |
0.7208 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD1613 | Approved |
0.7204 | Intermediate Similarity | NPD7697 | Approved |
0.7204 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7204 | Intermediate Similarity | NPD7698 | Approved |
0.72 | Intermediate Similarity | NPD2797 | Approved |
0.7195 | Intermediate Similarity | NPD7458 | Discontinued |
0.7192 | Intermediate Similarity | NPD9268 | Approved |
0.719 | Intermediate Similarity | NPD1699 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD2313 | Discontinued |
0.7188 | Intermediate Similarity | NPD2309 | Approved |
0.7186 | Intermediate Similarity | NPD5353 | Approved |
0.7186 | Intermediate Similarity | NPD4288 | Approved |
0.7171 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7166 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7166 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7162 | Intermediate Similarity | NPD1201 | Approved |
0.7152 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7152 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7152 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7151 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD17 | Approved |
0.7143 | Intermediate Similarity | NPD6535 | Approved |
0.7143 | Intermediate Similarity | NPD6534 | Approved |
0.7143 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7143 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7133 | Intermediate Similarity | NPD1283 | Approved |
0.7125 | Intermediate Similarity | NPD7003 | Approved |
0.7115 | Intermediate Similarity | NPD6653 | Approved |
0.7103 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7102 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7095 | Intermediate Similarity | NPD3496 | Discontinued |
0.7093 | Intermediate Similarity | NPD5242 | Approved |
0.7089 | Intermediate Similarity | NPD2438 | Suspended |
PubChem CID   | 9863860 |
ChEMBL   | CHEMBL1801951 |
ZINC   |
Molecular Weight:   | 364.15 |
ALogP:   | -1.812 |
MLogP:   | 2.78 |
XLogP:   | 2.348 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 113.29 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 26 |